Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Jnj source : Www.globenewswire.com save search
ArriVent Appoints Kristine Peterson to its Board of Directors
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
IMGN | News | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
| Email alert
Add to watchlist
White River Bancshares Co. Earns $509,000, or $0.51 Per Diluted Share, in First Quarter 2024; Highlighted by Higher Net Interest Income and Double Digit Loan and Deposit Growth Year-Over-Year
Published: 2024-04-19 (Crawled : 13:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
SBNY | News | $3.59 0.0% 280K
|
Finance
|
| O: 4.55%
H: 4.06%
C: 4.06%
first growth
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
RPRX | $27.83 -1.17% -1.19% 2.7M
|
Health Technology
|
| O: 1.07%
H: 1.22%
C: 1.11%
first pharma royalty financial results
Compass Diversified-Backed The Honey Pot Co. Strengthens Its Board With The Appointment of Three New Directors
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
CODI | $22.95 0.61% 0.0% 130K
|
Finance
|
| O: 0.36%
H: 0.0%
C: 0.0%
pot honey
Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
RPRX | $27.83 -1.17% -1.19% 2.7M
|
Health Technology
|
| O: -1.5%
H: 0.84%
C: 0.25%
pharma royalty
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
stelara fda biosimilar approval teva
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
RXRX | $7.605 3.47% 3.35% 3.8M
|
Professional, Scientific, and T...
|
| O: -9.4%
H: 2.1%
C: -0.53%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
commercial
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
GNMSF | News | $289.67 1.8% 3.83% 5.3K
|
Health Technology
|
| O: 4.94%
H: 0.0%
C: -3.66%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
GMAB | News | $28.97 0.94% 0.93% 450K
|
Health Technology
|
| O: -1.29%
H: 1.91%
C: 1.27%
darzalex sales first for
Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year
Published: 2024-04-12 (Crawled : 13:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
expected year revenue for financial
INVESTOR CALL: Virtualware's CEO to present Annual Report to shareholders
Published: 2024-04-11 (Crawled : 06:00) - globenewswire.com
AOMFF | News | $16.32 1.05% 95.45% 25
|
Producer Manufacturing
|
| O: 0.59%
H: 0.0%
C: -0.19%
ALSMY | News | $1.61 1.26% -1.78% 460K
|
Manufacturing
|
| O: 0.65%
H: 1.28%
C: 1.28%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
ceo report
Major shareholder announcement – BlackRock, Inc.
Published: 2024-04-10 (Crawled : 14:30) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
BLK | $760.11 1.35% 0.22% 500K
|
Finance
|
| O: -1.09%
H: 0.17%
C: -1.28%
announcement
Contineum Therapeutics Announces Pricing of Initial Public Offering
Published: 2024-04-05 (Crawled : 01:00) - globenewswire.com
MS | News 0 d | $92.09 1.58% 0.07% 4.9M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
TRIB | $1.8054 -3.87% 1.6K
|
Health Technology
|
| O: -0.99%
H: 2.0%
C: 2.0%
biotech business year financial results
HEALWELL AI’s Pentavere Achieves Validation of Generative AI for Preventative Care Through Landmark Publication
Published: 2024-04-04 (Crawled : 11:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
publication care
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
Published: 2024-04-04 (Crawled : 11:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
NXTC | $1.61 0.63% 0.0% 100K
|
Health Technology
|
| O: -4.17%
H: 8.26%
C: -6.09%
Major shareholder announcement – Swedbank Robur Fonder AB
Published: 2024-04-03 (Crawled : 14:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
announcement
Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
NBTX | $5.73 5.92% 7.84% 4K
|
Manufacturing
|
| O: 3.11%
H: 1.19%
C: -2.54%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
lung cancer treatment
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
Published: 2024-04-01 (Crawled : 13:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.04%
commercialization
Titan Medical Reports Fiscal Year 2023 Results
Published: 2024-03-29 (Crawled : 22:00) - globenewswire.com
TMDI | News | $0.14 -26.32% -35.52% 0
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
| Email alert
Add to watchlist
year medical results
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
CMPS | $8.36 -0.24% -0.6% 360K
|
Health Technology
|
| O: -1.79%
H: 0.21%
C: -10.83%
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
Your saved searches
Save your searches and get alerts when important news are released.